Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.93 | -22.01 |
PEG Ratio (TTM) | 0.02 | 15.69 |
P/S Ratio (TTM) | 1.08 | 48.43 |
P/B Ratio (TTM) | 1.18 | 18.71 |
P/FCF Ratio (TTM) | -0.59 | -2.79 |
Price to 5YR AVG Earnings Ratio | -0.42 | -3.21 |
Price to 5YR AVG FCF Ratio | -0.49 | -8.75 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -95.08% | -5.02% |
ROE (TTM) | -97.28% | 16.95% |
Net Profit Margin (TTM) | -114.12% | -1,552.13% |
ROIC 5YR AVG | 317.93% | 14.51% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -64.66% | -2,483.98% | -1,475.87% |
Revenue | -72.98% | 9.85% | 15.45% |
Net Income | -73.29% | -20.67% | -2.52% |
Cash Flow | 17.15% | -1,575.34% | -1,079.65% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.95 | 6.08 |
Quick Ratio (TTM) | 3.95 | 5.80 |
D/E Ratio (TTM) | N/A | -15.32 |
Interest Coverage (TTM) | -11.50 | -1.96 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 13.86 |
LTL to 5YR AVG FCF | N/A | 0.16 |
Shares Outstanding Growth 5YR AVG | -7.28% | 128.58% |